Human genetic evidence enriched for side effects of approved drugs.
Safety failures are an important factor in low drug development success rates. Human genetic evidence can select drug targets causal in disease and enrich for successful programs. Here, we sought to determine whether human genetic evidence can also enrich for labeled side effects (SEs) of approved d...
Saved in:
| Main Authors: | Eric Vallabh Minikel, Matthew R Nelson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-03-01
|
| Series: | PLoS Genetics |
| Online Access: | https://doi.org/10.1371/journal.pgen.1011638 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Search for a genetic cause of variably protease-sensitive prionopathy.
by: Yuan Lian, et al.
Published: (2025-08-01) -
Demand-side barriers and economic burden in accessing Human Papillomavirus screening for cervical cancer prevention in rural India: Evidence from a cross-sectional study [version 2; peer review: 1 approved, 2 approved with reservations, 2 not approved]
by: Swetha Chandrasekar, et al.
Published: (2025-02-01) -
Psychotropic Drugs and Ocular Side Effects
by: İpek Sönmez, et al.
Published: (2014-03-01) -
Cognitive Side Effects of Antiepileptic Drugs
by: J Gordon Millichap
Published: (2004-04-01) -
Drug interactions and side effects index /
Published: (1990)